Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-11-005005
Filing Date
2011-08-01
Accepted
2011-08-01 11:27:44
Documents
2
Period of Report
2011-07-20

Document Format Files

Seq Description Document Type Size
1 c66464_form3.html 3  
1 c66464_form3.xml 3 2781
2 c66464_ex24-1.htm EX-24.1 6484
  Complete submission text file 0000930413-11-005005.txt   10932
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854
Business Address
Greenberger Lee M (Reporting) CIK: 0001526711 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 11999579